Stock listing
Frankfurt:OXIA GT Biopharma, Inc. Aktie
German listing (Frankfurt) of GT Biopharma, Inc. · home listing NASDAQ:GTBP
Follow GT Biopharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:GTBP
$5.13 USD -0.19 (-3.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:GTBP
- Day range
- $5.11 – $5.40 USDNov 2, 2026
- Volume
- 33,594 sharesNov 2, 2026
- Market cap
- $10.57M USDAt the close on Nov 2, 2026 · price × 2.06M shares outstanding
- 52-week range
- $4.91 – $28.75 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $439,515 USDMedian day 31,765 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GTBP · Home | $5.13 USD | -0.19 (-3.6%) | 33,594 | $5.35 | $5.399 | $5.11 | $5.32 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:GTBP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.13 | -0.19 | -3.6% | $5.35 | $5.399 | $5.11 | 33,594 | |
| $5.32 | -0.28 | -5.0% | $5.47 | $5.535 | $5.30 | 20,169 | |
| $5.60 | +0.09 | +1.6% | $5.61 | $5.69 | $5.46 | 57,020 | |
| $5.51 | -0.07 | -1.3% | $5.39 | $5.69 | $5.32 | 54,778 | |
| $5.58 | +0.51 | +10.1% | $5.56 | $5.671 | $5.18 | 102,416 | |
| $5.07 | -0.39 | -7.1% | $5.49 | $5.78 | $5.07 | 178,775 | |
| $5.46 | -0.06 | -1.1% | $5.58 | $5.70 | $5.31 | 63,917 | |
| $5.52 | +0.11 | +2.0% | $5.37 | $5.57 | $5.28 | 69,418 | |
| $5.41 | -1.90 | -26.0% | $6.81 | $6.90 | $5.31 | 170,843 | |
| $7.31 | +0.62 | +9.3% | $6.63 | $7.49 | $6.63 | 49,369 | |
| $6.69 | -0.34 | -4.8% | $7.17 | $7.17 | $6.69 | 28,773 | |
| $7.03 | -0.33 | -4.5% | $7.14 | $7.32 | $6.86 | 55,290 | |
| $7.36 | +1.15 | +18.5% | $6.50 | $7.40 | $6.50 | 63,081 | |
| $6.21 | -0.29 | -4.5% | $6.44 | $6.44 | $5.86 | 42,148 | |
| $6.50 | -0.30 | -4.4% | $7.50 | $7.50 | $6.328 | 29,555 | |
| $6.80 | +0.12 | +1.8% | $6.79 | $7.05 | $6.50 | 37,956 | |
| $6.68 | +0.72 | +12.1% | $5.96 | $6.68 | $5.827 | 43,382 | |
| $5.96 | -0.24 | -3.9% | $6.20 | $6.22 | $5.80 | 31,765 | |
| $6.20 | -0.17 | -2.7% | $6.30 | $6.47 | $6.20 | 19,169 | |
| $6.37 | +0.21 | +3.4% | $6.31 | $6.45 | $6.20 | 22,404 | |
| $6.16 | +0.06 | +1.0% | $6.13 | $6.68 | $6.12 | 38,732 | |
| $6.10 | -0.10 | -1.6% | $6.36 | $6.51 | $6.00 | 62,624 | |
| $6.20 | -0.27 | -4.2% | $6.34 | $6.46 | $6.00 | 39,000 | |
| $6.47 | -0.405 | -5.9% | $6.85 | $7.017 | $6.47 | 29,759 | |
| $6.875 | +0.075 | +1.1% | $7.08 | $7.10 | $6.71 | 34,968 | |
| $6.80 | -0.09 | -1.3% | $7.00 | $7.25 | $6.79 | 36,975 | |
| $6.89 | +0.06 | +0.9% | $6.79 | $7.24 | $6.59 | 79,842 | |
| $6.83 | -0.27 | -3.8% | $7.01 | $7.10 | $6.59 | 28,216 | |
| $7.10 | -0.08 | -1.1% | $7.08 | $7.275 | $6.825 | 53,725 | |
| $7.18 | 0.00 | 0.0% | $7.12 | $7.20 | $6.35 | 74,674 | |
| $7.18 | +0.02 | +0.3% | $7.16 | $7.82 | $6.88 | 57,706 | |
| $7.16 | -0.33 | -4.4% | $7.52 | $7.52 | $7.11 | 37,473 | |
| $7.49 | -0.32 | -4.1% | $7.80 | $7.80 | $6.33 | 110,655 | |
| $7.81 | -1.19 | -13.2% | $9.04 | $9.04 | $7.31 | 107,923 | |
| $9.00 | -2.63 | -22.6% | $10.48 | $10.48 | $8.13 | 335,285 | |
| $11.63 | +3.02 | +35.1% | $8.69 | $11.98 | $8.65 | 524,297 | |
| $8.61 | +2.43 | +39.3% | $6.59 | $8.82 | $6.59 | 544,275 | |
| $6.18 | +0.20 | +3.3% | $6.13 | $6.74 | $5.50 | 161,354 | |
| $5.98 | +0.741 | +14.1% | $5.47 | $6.24 | $5.12 | 120,047 | |
| $5.24 | -0.785 | -13.0% | $5.62 | $5.95 | $4.91 | 88,497 | |
| $6.025 | -0.285 | -4.5% | $6.438 | $6.50 | $5.552 | 1,876 | |
| $6.31 | -0.765 | -10.8% | $7.025 | $7.14 | $6.31 | 1,785 | |
| $7.075 | -0.147 | -2.0% | $7.00 | $7.248 | $7.00 | 394 | |
| $7.222 | +0.072 | +1.0% | $7.25 | $7.25 | $7.00 | 403 | |
| $7.15 | -0.35 | -4.7% | $7.75 | $7.967 | $7.143 | 503 | |
| $7.50 | -0.045 | -0.6% | $7.65 | $7.85 | $7.50 | 599 | |
| $7.545 | +0.292 | +4.0% | $7.375 | $7.59 | $7.27 | 636 | |
| $7.253 | -0.24 | -3.2% | $7.45 | $7.45 | $7.153 | 334 | |
| $7.493 | -0.152 | -2.0% | $7.863 | $7.873 | $7.45 | 707 | |
| $7.645 | +0.43 | +6.0% | $7.253 | $7.95 | $7.128 | 1,031 | |
| $7.215 | +0.165 | +2.3% | $7.055 | $7.375 | $7.053 | 405 | |
| $7.05 | -0.123 | -1.7% | $7.25 | $7.25 | $6.888 | 317 | |
| $7.172 | +0.288 | +4.2% | $6.885 | $7.25 | $6.85 | 577 | |
| $6.885 | -0.24 | -3.4% | $7.125 | $7.125 | $6.725 | 858 | |
| $7.125 | -0.275 | -3.7% | $7.25 | $7.323 | $7.035 | 868 | |
| $7.40 | -0.035 | -0.5% | $7.375 | $7.655 | $7.178 | 1,286 | |
| $7.435 | -0.117 | -1.6% | $7.53 | $7.625 | $7.375 | 820 | |
| $7.552 | -0.268 | -3.4% | $8.00 | $8.013 | $7.53 | 896 | |
| $7.82 | -0.195 | -2.4% | $8.275 | $8.365 | $7.75 | 360 | |
| $8.015 | +0.013 | +0.2% | $8.003 | $8.293 | $7.763 | 658 | |
| $8.003 | +0.478 | +6.3% | $7.525 | $8.188 | $7.525 | 913 | |
| $7.525 | -0.413 | -5.2% | $7.938 | $8.095 | $7.515 | 400 | |
| $7.938 | -0.215 | -2.6% | $8.088 | $8.30 | $7.833 | 404 | |
| $8.153 | +0.438 | +5.7% | $7.75 | $8.37 | $7.748 | 679 | |
| $7.715 | +0.378 | +5.1% | $7.285 | $7.89 | $7.178 | 671 |
- Ticker
- Frankfurt:OXIA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 26, 2026
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Calls
Replays
GT Biopharma (NASDAQ:GTBP) Q2 2021 Earnings Call
Fri, Aug 13, 2021 · 8:30 AM ET
Watch Transcript
Latest news
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Oct 26, 2026
Closed $5.07 (-7.1%) on Oct 26, 2026
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
Sep 15, 2026
Closed $9.00 (-22.6%) on Sep 15, 2026
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
Sep 11, 2026
Closed $8.61 (+39.3%) on Sep 11, 2026
GT Biopharma Reports Second Quarter 2026 Financial Results
Aug 14, 2026
Closed $7.40 (-0.5%) on Aug 14, 2026
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Jun 8, 2026
Closed $10.63 (-2.6%) on Jun 8, 2026
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
Jun 1, 2026
Closed $11.05 (-7.6%) on Jun 1, 2026
GT Biopharma Reports First Quarter 2026 Financial Results
May 15, 2026
Closed $9.85 (-10.3%) on May 15, 2026
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
May 14, 2026
Closed $10.97 (+40.4%) on May 14, 2026
GT Biopharma to Participate in the 38th Annual Roth Conference
Mar 11, 2026
Closed $11.00 (+5.7%) on Mar 11, 2026
Amendment to Quarterly Report (Form 10-Q/A)
Mar 6, 2026
Closed $10.42 (-11.1%) on Mar 9, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · September 2026
Investor Presentation (January 2025)
Investor deck · 25 slides · Jan 27, 2025
Investor Presentation (November 2021)
Investor deck · 33 slides · Nov 1, 2021
Investor Presentation (September 2021)
Investor deck · 24 slides · Sep 23, 2021
GT Biopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 112 in all · newest Oct 26, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 13, 2021
- Decks
- 10 decks · latest September 2026
Where GT Biopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GTBP · Home listing | NASDAQ | United States | USD |
| BOATS:GTBP | BOATS | United States | USD |
| gettex:OXIA | gettex | Germany | EUR |
| Munich:OXIA | Munich | Germany | EUR |
| Stuttgart:OXIA | Stuttgart | Germany | EUR |
| Frankfurt:OXIA · This page | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about GT Biopharma, Inc.